đź§Ş What It Is
Active compound:Â Retatrutide
Class:Â Triple hormone receptor agonist
Targets:
GLP-1 (glucagon-like peptide-1)
GIP (glucose-dependent insulinotropic polypeptide)
Glucagon receptor
Form:Â Subcutaneous injection via prefilled pen
Retatrutide is not an anabolic steroid. It belongs to a newer class of metabolic peptides being studied for obesity, insulin sensitivity, and cardiometabolic risk reduction.
🧬 How It Works
Retatrutide is unique because it activates three key metabolic pathways at once:
GLP-1:Â Reduces appetite, slows gastric emptying, improves glucose control
GIP:Â Enhances insulin signaling and metabolic efficiency
Glucagon receptor:Â Increases energy expenditure and fat oxidation
This triple action is designed to promote significant fat loss while preserving lean mass more effectively than single-pathway agents.
đź’ˇ Commonly Associated Effects
In clinical research settings, retatrutide has been associated with:
Marked appetite suppression
Significant body fat reduction
Improved blood glucose control
Increased metabolic rate
Potential improvements in lipid profiles
It is often discussed alongside compounds like semaglutide and tirzepatide, but with a broader metabolic mechanism.
đź’‰ Pen Format
Delivery:Â Subcutaneous injection
Presentation:Â Disposable or multi-use prefilled pen
Labeling:Â Compound name (Retatrutide), total content (30 mg), batch/lot details
Pens are designed for precise, consistent dosing, though exact dosing protocols depend on medical guidance
